A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Public ClinicalTrials.gov record NCT01305824. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Double-Blind, Placebo-Controlled Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Study identification
- NCT ID
- NCT01305824
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Proteon Therapeutics
- Industry
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Interventions
- PRT-201 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2011
- Primary completion
- Oct 31, 2012
- Completion
- Oct 31, 2012
- Last update posted
- Apr 29, 2015
2011 – 2012
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Institute of Renal Research | San Diego | California | 92123 | — |
| Kaiser Permanente | San Diego | California | — | — |
| UCSF | San Francisco | California | — | — |
| Rush Medical Center | Chicago | Illinois | — | — |
| Renal Care Associates | Peoria | Illinois | — | — |
| Indiana Ohio Heart | Fort Wayne | Indiana | — | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Louisville | Louisville | Kentucky | — | — |
| Vascular Specialty Center | Baton Rouge | Louisiana | — | — |
| Beth Israel Deconness Hospital | Boston | Massachusetts | — | — |
| Brigham and Women's Hospital | Boston | Massachusetts | — | — |
| UMASS Medical Center | Worcester | Massachusetts | — | — |
| St Clair Specialty Physicians | Detroit | Michigan | — | — |
| Thoracic & Cardiovascular Healthcare Foundation | Lansing | Michigan | — | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| Montefiore Medical Center | The Bronx | New York | — | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Legacy Oregon Surgical | Portland | Oregon | — | — |
| Lehigh Valley Hospital | Allentown | Pennsylvania | — | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| The Methodist Hospital | Houston | Texas | 77030 | — |
| Sentara Medical Group | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01305824, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2015 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01305824 live on ClinicalTrials.gov.